Zhengye Biotechnology Holding Ltd (ZYBT): Total Assets

Annual figures by period end, from SEC filings.

436.47M CNY
As of 2025-12-31
499.89M CNY2023-12-31: 499.89M CNY2024-12-31: 493.25M CNY2025-12-31: 436.47M CNY436.47M CNY
2023-12-31 Total Assets (CNY) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31436.47M CNY-11.5%2026-04-28, Balance as of period end
2024-12-31493.25M CNY-1.3%2026-04-28, Balance as of period end
2023-12-31499.89M CNYn/a2025-07-03, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Zhengye Biotechnology Holding Ltd (ZYBT)2025-12-31436.47M CNY-11.5%
Yatsen Holding Ltd (YSG)2025-12-313.85B CNY-3.1%

Compare ZYBT, YSG side by side · Screen every company in Pharmaceutical Preparations ↗